GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Fluidigm Corporation (ADR) (FLDM) [hlAlert]

Rating:
Buy FLDM
down 30.09 %

Fluidigm Corporation (ADR) (FLDM) rated Buy with price target $65 by Maxim Group

Posted on: Friday,  Mar 21, 2014  8:25 AM ET by Maxim Group

Maxim Group rated Buy Fluidigm Corporation (ADR) (NASDAQ: FLDM) on 03/21/2014. Previously Maxim Group rated Buy Fluidigm Corporation (ADR) (NASDAQ: FLDM) on
06/27/2013., when the stock price was $16.28. Since then, Fluidigm Corporation (ADR) has lost 30.10% as of 01/22/2016's recent price of $11.38.
If you would have followed the previous Maxim Group's recommendation on FLDM, you would have lost 30.09% of your investment in 939 days.

Fluidigm Corporation (Fluidigm) develops, manufactures and markets integrated fluidic circuit systems. The Company?s microfluidic systems consist of instruments and consumables, including chips and reagents. It markets three microfluidic systems, including eight different commercial chips to pharmaceutical and biotechnology companies, academic institutions, diagnostic laboratories and Ag-Bio companies. As of December 31, 2010, Fluidigm had sold over 300 systems to customers in over 20 countries worldwide. As of December 31, 2010, it was developing products for use in molecular diagnostics and other markets. The Company sells three microfluidic systems, BioMark, EP1 and Access Array. All of its systems include chip controllers that control the activation of valves, loading of reagents, and recovery or wash steps within the chips. Each chip controller comes with software to control chip and instrument operations for particular applications.

At Maxim Group, our vision for equity research is to be a client’s first call for value-added research on companies not widely followed by Wall Street. Maxim’s premier niche is emerging-growth companies in a variety of sectors, including healthcare, technology, retail and others. As strong believers in fundamental research, our analysts utilize a “bottom up” approach to making investment recommendations. We combine rigorous financial analysis of specific companies and industries with due diligence that includes frequent consults with suppliers, customers, competitors and senior management. By applying these skills and techniques, we are able to offer our clients differentiated research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
3/21/2014 8:25 AM Buy
None
47.53 65.00
as of 10/17/2014
1 Week up  16.04 %
1 Month down  -10.01 %
3 Months down  -5.77 %
1 YTD down  -33.12 %
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
12/18/2013 8:25 AM Buy
None
34.50 42.00
10/31/2013 9:25 AM Buy
None
30.70 33.00
8/2/2013 10:25 AM Buy
None
19.71 23.00
6/27/2013 8:25 AM Buy
None
16.28 21.00

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy